Market research
FUP.F Fuji Pharma Co., Ltd
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 255M
- P/E ratio
- 18.4
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- 0.33
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- JP3816200004
- Market cap
- 255M
- P/E ratio
- 18.4
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- 0.33
About
About Fuji Pharma Co., Ltd
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FUP.F discussion.
5 years, 5 months ago
Fuji Pharma Co., Ltd is currently in a long term uptrend where the price is trading 6.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Fuji Pharma Co., Ltd's total revenue rose by 3.6% to $9B since the same quarter in the previous year.
Its net income has increased by 78.3% to $1B since the same quarter in the previous year.
Based on the above factors, Fuji Pharma Co., Ltd gets an overall score of 4/5.